Modem understanding of the physiology of sound conduction through the middle ear emphasises the importance of the ossicles acting only as a piston without significant rotation about the joints. 4 In man the incudomalleal joint seems to have no function apart from binding the two bones together as there is no movement at the joint. Indeed in many rodents there is no joint and the malleus and incus are one bone. The most important factor changing the low pressure, high displacement vibrations of air into high force, low displacement vibrations suitable for driving cochlear fluids is the ratio of the areas of the tympanic membrane and the stapes footplate. Therefore, the presumption that these joints should participate in the rheumatoid process seems far less likely. Interestingly, however, this study and those of Reiter2 and Moffat5 all showed altered stiffness of the middle ear conducting mechanism. Goodwill, who examined the ossicles removed at necropsy from three rheumatoid patients, did not find nodules or erosive joint changes but instead fibrous tissue replacement of the long process of the incus.6 This finding is not uncommon in chronic otitis media and is thought to result from the fact that the long process of the incus has the most tenuous blood supply of all the ossicular elements and thus is most at risk from endarteritis obliterans secondary to infection with subsequent resorption of bone and replacement by fibrosis. Probably, the middle ear changes in rheumatoid arthritis are secondary to the associated vasculitis, which is already known to account for most of the other extra-articular manifestations. The course of her disease was unremarkable and did not feature the destructive peripheral arthropathy noted in the previous reports. At her last assessment her disease activity was subjectively moderate, with no morning stiffness and with lower back pain rated as 26% of maximum on a visual analogue scale. The modified Schober index2 was 5 cm, chest expansion 2 cm, and she had no peripheral synovitis or enthesitis. Erythrocyte sedimentation rate was 43 mm/lst h, C reactive protein 27 mg/l (normal <10).
The patient was otherwise healthy, and IgA deficiency was not suspected on clinical grounds. During serological studies ofa sample of patients with ankylosing spondylitis (to be reported separately) she was noted to have barely detectable concentrations of specific IgA antibodies. Serum total IgA concentration was <0-2 g/l (normal range 0-8-3-9) by laser nephelometry, and <50 mg/l by enzyme linked immunosorbent assay (ELISA). By contrast, her serum IgM was normal at 1-3 g/l (0-5-3-5), and IgG slightly raised at 17-1 g/l (7-2-16-2). Bone marrow examination was not indicated.
Although selective IgA deficiency has been associated with recurrent mucosal infection and allergy, and with an increased incidence of several autoimmune disorders, most patients are asymptomatic.3 IgA deficiency affects about 0-2% of the adult white population,3 and ankylosing spondylitis up to 1%.4 By chance alone the two disorders will therefore occur together in 0-002% (one in 50 000 people), suggesting that there are around 1000 such patients in the United Kingdom. Unlike the four previously reported cases' our patient did not have 'severe' ankylosing spondylitis, and we argue against interpreting IgA deficiency as a poor prognostic factor in ankylosing spondylitis until more evidence has been accumulated.
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